Kala Pharmaceuticals prices $90m IPO

Kala Pharmaceuticals (NSDQ:KALA) today priced its initial public offering of 6 million shares of common stock at $15.00 apiece. The IPO is slated to bring in nearly $90 million for the Waltham, Mass.-based company.
The offering, which is expected to close on July 25, includes a 30-day option for underwriters to buy up to 900,000 additional shares of common stock.
Get the full story at our sister site, Drug Delivery Business News.
The post Kala Pharmaceuticals prices $90m IPO appeared first on MassDevice.

Source: Mass Device - July 20, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Funding Roundup Initial Public Offering (IPO) Optical/Ophthalmic Pharmaceuticals Wall Street Beat Kala Pharmaceuticals Source Type: news